TargEDys raises $6.5 mln for drugs to regulate appetite
TargEDys, which develops drugs and other medical products to regulate appetite, announced it has raised 5.8 million euros ($6.53 million) in a Series A round from Seventure Partners, NCI and Pontifax. The Rouen, France-based company will use the financing to launch human clinical studies for its products.
14 April 2016•5 mins read
